DylanMcIntyre

Associate

Brisbane + 61.7.3085.7038

Dylan McIntyre has more than 10 years of experience providing strategic advice on a wide range of competition and regulatory law issues, including Australian and cross-border merger clearances, joint ventures, regulated industries, cartels, anticompetitive conduct, and Australian Competition & Consumer Commission (ACCC) investigations.

Dylan has extensive experience counseling clients at all stages of complex, high-profile matters from initial tactical planning, to responding to compulsory notices, drafting compelling submissions, and negotiating favorable outcomes.

Dylan's experience covers a wide variety of sectors, including mining, energy and renewables, ports, rail and gas infrastructure, aviation, health care, financial services, FMCG (fast-moving consumer goods), transport, and logistics across Australia, the United Kingdom, and Europe.

Experience

  • Intelligent Monitoring Group acquires ADT security businessJones Day advised ASX-listed Intelligent Monitoring Group Ltd on its A$45 million acquisition of the ADT security monitoring business in Australia and New Zealand (through the acquisition of Tyco Australia Group Pty Ltd) and the associated A$80 million acquisition finance facility and A$17 million equity raising undertaken by accelerated entitlement offer and a top-up placement.
  • Andrew Dzurak and Allectus Capital create leading quantum computing company, Diraq Pty LtdJones Day acted for Professor Andrew Dzurak and Allectus Capital, in the creation of a leading quantum computing company, Diraq Pty Ltd (formerly, SiMOS Newco Pty Ltd) whose founding shareholders consist of the University of New South Wales, Allectus Capital and Professor Dzurak.
  • LGIAsuper acquires Suncorp’s superannuation businessJones Day advised LGIAsuper in the $45 million acquisition of Suncorp’s superannuation business, through the acquisition of Suncorp Portfolio Services Limited (SPSL).
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • The following represents experience acquired prior to joining Jones Day.

    Advised Santos on its US$2.15 billion acquisition of Quadrant Energy (Deal of the Year, 2019 Asia Pacific Energy Awards).

    Advised Wesfarmers on competition issues related to its $20 billion demerger of Coles (M&A Deal of the Year, 2019 Australasian Law Awards).

    Advised a large energy company in the ACCC's gas market inquiry.

    Represented Telefónica in the European Commission's Phase II investigation into the £10.25 billion sale of its UK mobile business (O2) to Hutchison Whampoa.

    Represented Arriva on the UK Competition and Markets Authority's Phase 2 investigation of its acquisition of the £7.2 billion Northern Rail franchise.

    Advised Ventia on competition matters (including ACCC merger clearance) regarding its acquisition of Broadspectrum for an equity value of $485 million.

    Advised Suncorp on various matters, including its sale of a 90% interest in Capital Smart and ACM Parts to AMA and the sale of its life insurance business to TAL Daichi Life.

    Advised Aconex in relation to the $1.6 billion acquisition by Oracle by scheme of arrangement, including advising on ACCC and overseas merger clearances.

    Represented the Queensland Resources Council, Queensland's peak mineral and energy resource body, on the Queensland government's declaration of the Central Queensland Coal Network.